- The Delta variant accounts for 93% of cases in the U.S. The National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci warned about the possible emergence of new variants.
- Moderna also believes regular booster shots will be necessary to maintain protection against COVID-19 and its variants.
- San Francisco is considering allowing recipients of the Johnson & Johnson vaccine to receive a dose of the Pfizer or Moderna vaccine as a booster.
- Preliminary results shows that a new inhalable nanobody treatment based on the immune systems of llamas was an effective treatment against the Delta variant.
- The CDC has updated its website and guidelines – some with a large focus on back to school – including Guidance for COVID-19 Prevention in Kindergarten (K)-12 Schools; What to do if a Student Becomes Sick at School or Reports a New COVID-19 Diagnosis Flowchart; and Know What to Expect at Your Child’s K- 12 School or Child Care Program.
White House and Federal Agencies
- The White House is planning a global summit for world leaders to discuss ending the pandemic.
- The White House held private meetings with major news networks to discuss how they cover new information about COVID-19.
- The United States has distributed 110 million doses of COVID-19 vaccines to other countries.
Economy, Vaccines, Testing and Treatment
- Vaccination rates have significantly increased in the last few days.
- The Delta variant accounts for 93% of cases in the U.S.
- The Food and Drug Administration (FDA) could give full approval to Pfizer’s COVID-19 vaccine by early November. All COVID-19 vaccines are currently approved under an Emergency Use Authorization (EUA). Some public health experts believe full approval will lead to increase vaccination rates.
- Moderna says its vaccine is 93% effective six months after the second dose was administered.
- Moderna also believes regular booster shots will be necessary to maintain protection against COVID-19 and its variants.
- The FDA approved Regeneron’s COVID-19 antibody therapy as a preventative treatment for people with immunocompromising health conditions such as HIV.
- A new survey from the Kaiser Family Foundation shows consistent levels of vaccine hesitancy. It also shows divergent views on the danger of the Delta variant held by vaccinated and unvaccinated respondents.
- Novavax agreed to provide 200 million doses of its COVID-19 vaccine to the European Union
- The World Health Organization (WHO) is asking countries to avoid booster doses so that vaccine supply can be used by other countries to first increase their vaccination rates.
- San Francisco is considering allowing recipients of the Johnson & Johnson vaccine to receive a dose of the Pfizer or Moderna vaccine as a booster.
- New research shows that the number of women in the healthcare workforce declined by 27,000 during the first five months of 2021.
- Preliminary results show that a new inhalable nanobody treatment based on the immune systems of llamas was an effective treatment against the Delta variant.
- The American Medical Association (AMA) announced a new CPT code for a third dose of the Pfizer COVID-19 vaccine.
Centers for Disease Control and Prevention (CDC) Updates
- The CDC published the following reports and website updates:
- COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years – United States, December 14, 2020-July 16, 2021
- Cases in the U.S.
- Guidance for COVID-19 Prevention in Kindergarten (K)-12 Schools
- What to do if a Student Becomes Sick at School or Reports a New COVID-19 Diagnosis Flowchart
- Know What to Expect at Your Child’s K- 12 School or Child Care Program
- COVID-19 and Animals
- Families with Vaccinated and Unvaccinated Members
- CDC Issues Eviction Moratorium Order in Areas of Substantial and High Transmission
- Federal Register Notice: Temporary Halt in Residential Evictions to Prevent the Further Spread of COVID-19
- Laws and Regulations
- CDC Extends Order at the Southern and Northern Land Borders
- What to Consider When Planning to Operate a COVID-19 Vaccine Clinic
- Families & Children
- Selected Adverse Events Reported after COVID-19 Vaccination
